Biden team divided on vaccine patent waivers

Written by Annette

Divisions within the Biden administration persist over whether to ease some patent restrictions on vaccines, according to people familiar with the matter, as the President nears a decision on loosening some intellectual property rules on pharmaceutical products, a move that could expand global vaccine supply.


About the author


Leave a Comment